Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 23 Jul 2025

CDFA: Calibrated deep feature aggregation for screening synergistic drug combinations

in Pharmacology of Anti-Cancer Drugs

Xiaorui Kang
Xiaoyan Liu
Quan Zou
Tiantian Li
Ximei Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1608832

153 views

Review

Published on 23 Jul 2025

The role of ubiquitination and deubiquitination in urological tumours

in Pharmacology of Anti-Cancer Drugs

Lifeng Gan
Peiyue Luo
Junrong Zou
Wei Li
Qi Chen
Le Cheng
Fangtao Zhang
Haidong Zhong
Liying Zheng
Biao Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532878

105 views

Case Report

Published on 23 Jul 2025

Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Panpan Ji
Yahui Zhang
Wen Zhang
Bing Leng
Ruifang Nie
Chengwu Shen
Hengcai Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499796

177 views

Original Research

Published on 23 Jul 2025

Emerging trends and knowledge networks in pan-cancer sorafenib resistance: a 20-year bibliometric investigation

in Pharmacology of Anti-Cancer Drugs

Qiong Zhou
Rui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1581820

120 views

Original Research

Published on 23 Jul 2025

Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma

in Pharmacology of Anti-Cancer Drugs

Xiao-Qing Shi
Xiao-Tong Liu
Xiao-Hui Liu
Hui-Wen Geng
Zhuo Zhang
Wei-Yi Wang
Xing Chen
Xian Zhao
Bo-Lin Jue
Bo Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542159

109 views

Case Report

Accepted on 22 Jul 2025

Case Report: Treatment Response of SQSTM1 -ALK Fusion Lung Adenocarcinoma Treated with Multiple ALK Inhibitors

in Pharmacology of Anti-Cancer Drugs

Jincui Gu
Jing Zhang
Shaoli Li
Ziying Lin
Lixia Huang
Yanbin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1608080

Original Research

Accepted on 22 Jul 2025

Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma

in Pharmacology of Anti-Cancer Drugs

Wenshu Li
Sitian Zhang
Ruoyun Wu
Ying Li
Shifeng Wei
Lin Fu
Xuefei Sun
Yuanbo Liu
Zhigang Zhao
Shenghui Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561818

Review

Accepted on 22 Jul 2025

Multimodal Integration Strategies for Clinical Application in Oncology

in Pharmacology of Anti-Cancer Drugs

Baoyi Zhang
Zhuoya Wan
Yige Luo
Xi Zhao
Josue Samayoa
Weilong Zhao
Si Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609079

Original Research

Published on 22 Jul 2025

Integrative genomic analysis identifies DPP4 inhibition as a modulator of FGF17 and PDGFRA downregulation and PI3K/Akt pathway suppression leading to apoptosis

in Pharmacology of Anti-Cancer Drugs

Kiran Kumar Chitluri
Emerson Isaac Arnold

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606914

287 views

Systematic Review

Published on 22 Jul 2025

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Huiyan Yang
Xiaoxiao Xu
Mei Tan
Jingyu Gao
Ruihan Fang
Xuan Liu
Zhaokun Chen
Libai Chen
Yongsheng Ruan
Yiqi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549214

219 views

Original Research

Accepted on 21 Jul 2025

Prognostic Value of Inflammatory Markers and Different Treatment Regimens in Neuroendocrine Cervical Carcinoma: A Retrospective Study

in Pharmacology of Anti-Cancer Drugs

Mingqin Kuang
Qi Wang
Ying Yu
Changmei Shen
Tao Peng
Meili Li
Xiyun Cheng
Jing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1652092

Original Research

Accepted on 21 Jul 2025

Integrative analysis of lactylation related genes in prostate cancer: unveiling heterogeneity through single-cell RNA-seq, bulk RNA-Seq and machine learning

in Pharmacology of Anti-Cancer Drugs

Chenghao Zhou
Lifeng Ding
Huailan Wang
Gonghui Li
Lei Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1634985

124 views

Mini Review

Accepted on 21 Jul 2025

Drug-Tolerant Persister (DTP) Cell in Cancer: Reversibility, Microenvironmental Interplay, and Therapeutic Strategies

in Pharmacology of Anti-Cancer Drugs

Haifeng Li
Wenlong Xu
Wenqi Cheng
Dongmei Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1612089

121 views

Review

Accepted on 21 Jul 2025

Anti-tumor effects and mechanisms of traditional Chinese medicine Gamboge: a review

in Pharmacology of Anti-Cancer Drugs

Yanqing Zhou
Jialing Chen
Qin Zhu
Binyan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1650560

Case Report

Accepted on 18 Jul 2025

Case Report: Locally advanced lung adenocarcinoma with a novel MIR217HG-ALK rearrangement responding to neoadjuvant alectinib

in Pharmacology of Anti-Cancer Drugs

Yinyin Xue
Wen Li
KaiLi Huang
Qinghua Zhou
Qiang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602654

146 views

Original Research

Accepted on 18 Jul 2025

Deciphers the role of myofibroblasts in microvascular invasion of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Xiang Liu
Jiangyang Pan
Lijia Wang
Qiao Xie
Tianbo Fan
Qi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596181